SAB Biotherapeutics, Inc. (SABS) - Quarterly Balance Statement

Home
SABS
Financials

2.18 (USD) • At close February 5, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4
Assets:
Current Assets:
Cash & Cash Equivalents Numbers are in millions	9.171	17.242	14.034	56.566	2.425	7.774	13.06	15.047	8.332	16.616	22.408	33.207	0.668	10.233	0.858	12.61
Short Term Investments Numbers are in millions	21.229	20.084	30.023	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash and Short Term Investments Numbers are in millions	30.401	37.326	44.057	56.566	2.425	7.774	13.06	15.047	8.332	16.616	22.408	33.207	0.668	10.233	0.858	12.61
Net Receivables Numbers are in millions	0.097	0.225	0.193	0	0	0.364	0.763	5.557	12.942	9.613	11.786	8.011	0	17.109	0	20.569
Inventory Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Current Assets Numbers are in millions	2.039	2.03	2.701	2.341	0.702	0.868	1.209	1.494	0.908	1.521	1.975	8.975	0.103	0.427	0.263	1.275
Total Current Assets Numbers are in millions	32.537	39.58	46.951	58.907	3.128	9.006	15.032	22.097	22.182	27.751	36.17	48.42	0.771	27.769	1.121	34.455
Non-Current Assets:
Property, Plant & Equipment, Net Numbers are in millions	20.746	21.79	22.631	24.684	24.837	26.002	27.206	28.34	29.824	30.869	31.303	30.949	0	26.443	0	22.083
Goodwill Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Goodwill and Intangible Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long Term Investments Numbers are in millions	0	0	1.235	0	0	0	0	0	0	0	0	0	116.158	116.155	116.152	0
Tax Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets Numbers are in millions	0.514	0.522	0.554	0.35	0.371	0.434	0.434	0.468	0.501	0.535	0	0	0	-116.155	0	0
Total Non-Current Assets Numbers are in millions	21.26	22.311	24.42	25.034	25.209	26.436	27.64	28.807	30.325	31.404	31.303	30.949	116.158	26.443	116.152	22.083
Total Assets Numbers are in millions	53.797	61.892	71.371	83.941	28.336	35.443	42.672	50.905	52.507	59.155	67.472	79.369	116.929	54.212	117.273	56.538
Liabilities & Equity:
Current Liabilities:
Account Payables Numbers are in millions	1.297	1.171	1.24	0.946	1.083	1.404	1.445	3.679	5.484	4.944	4.981	4.459	0	5.498	0	7.382
Short Term Debt Numbers are in millions	0.525	1.808	1.513	2.655	1.858	1.458	1.095	1.396	2.733	2.645	2.626	1.49	0	1.16	0	1.658
Tax Payables Numbers are in millions	0	0	0	0.04	0.03	0.02	0.05	0.05	0.083	0.033	0.142	0.216	0	0	0	0
Deferred Revenue Numbers are in millions	0.115	0.115	0.378	1.322	1.627	2.895	2.939	0	0	0	0	0.1	0	0.1	0	0.1
Other Current Liabilities Numbers are in millions	6.88	6.079	8.429	5.85	4.612	5.235	8.136	9.868	8.802	8.516	10.506	18.419	0.322	3.438	0.08	1.922
Total Current Liabilities Numbers are in millions	8.816	7.552	8.305	10.813	9.211	11.011	13.666	14.993	17.101	16.137	18.256	24.684	0.322	10.197	0.08	11.062
Non-Current Liabilities:
Long Term Debt Numbers are in millions	3.996	4.131	3.938	4.054	3.452	4.119	4.365	4.533	4.425	4.756	5.088	5.416	0	5.757	0	6.468
Deferred Revenue Non-Current Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Tax Liabilities Non-Current Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities Numbers are in millions	4.083	4.089	6.306	11.774	0.417	0.596	0.238	0.321	0.358	1.14	2.871	10.72	9.75	0	7.803	0
Total Non-Current Liabilities Numbers are in millions	8.078	8.22	10.244	15.828	3.87	4.715	4.604	4.853	4.783	5.896	7.958	16.136	9.75	5.757	7.803	6.468
Total Liabilities Numbers are in millions	16.895	15.772	18.549	26.642	13.08	15.726	18.269	19.847	21.884	22.034	26.214	40.819	10.072	15.953	7.883	17.53
Equity:
Preferred Stock Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0.002	0	0.002
Common Stock Numbers are in millions	0.001	0.001	0.001	0.001	0.005	0.005	0.005	0.005	0.004	0.004	0.004	0.004	116.15	0.004	104.39	0.004
Retained Earnings Numbers are in millions	-112.774	-102.425	-95.089	-90.064	-67.207	-62.104	-55.224	-47.87	-39.995	-32.919	-28.143	-29.129	-9.294	-13.516	2.964	-11.984
Accumulated Other Comprehensive Income/Loss Numbers are in millions	0.052	-0.031	-0.063	0.026	0	0	0	0	0	0	0	0	0	0	0	0
Other Total Stockholders Equity Numbers are in millions	149.624	148.575	147.973	147.336	82.457	81.816	79.621	78.923	70.614	70.036	69.397	67.675	0	51.769	2.035	50.99
Total Shareholders Equity Numbers are in millions	36.903	46.12	52.822	57.299	15.256	19.716	24.403	31.058	30.623	37.121	41.258	38.55	106.857	38.259	109.39	39.008
Total Equity Numbers are in millions	36.903	46.12	52.822	57.299	15.256	19.716	24.403	31.058	30.623	37.121	41.258	38.55	106.857	38.259	109.39	39.008
Total Liabilities & Shareholders Equity Numbers are in millions	53.797	61.892	71.371	83.941	28.336	35.443	42.672	50.905	52.507	59.155	67.472	79.369	116.929	54.212	117.273	56.538

SAB Biotherapeutics, Inc.

NASDAQ:SABS Add to watchlist

NASDAQ:SABS